Both HIV-1 infection and active cocaine use are associated with a myriad of cardiovascular diseases including accelerated atherosclerosis. Cocaine mediates some effects via the catecholamines, while both HIV-1 infection and cocaine use are associated with immunological dysregulation. Since atherosclerosis appears to be mediated immunologically, we postulate that inflammatory cytokines and nitrite secreted by mast cells and endothelial cells activated by cocaine and HIV infection modulate macrophage function and hence atherogenesis. We will answer the following questions: 1) Are activated human mast cells and coronary endothelial cells capable of expressing factors that mediate atherogenesis, namely specific chemokines (Interleukin-8 [IL-8], monocyte chemotactic protein-1 [MCP-1]), cytokines regulating the acute phase response (IL-6 and tumor necrosis factor alpha [TNF-alpha]) and macrophage colony stimulating factor [M-CSF]? Is there activation of protein kinase C (PKC) and nuclear factor-kB, (NF-kappaB)? Is this activation modulated by inhibitors of PKC and NF-kappaB? 2) Do cocaine and catecholamines alone or in combination with the HIV-1 proteins (gp 120 and tat) induce human coronary endothelial and mast cell activation resulting in induction of PKC and NF-kappaB and the elaboration of nitric oxide and tryptase, IL-6, IL-8, TNF-alpha, MCP-1 and M-CSF? Is this activation affected by inhibitors of PKC and NF-kappaB? 3) Do patients with HIV-1 infection have higher plasma levels of nitric oxide and tryptase, IL-6, IL-8, TNF-alpha, MCP-1 and M-CSF? Do these levels differ in patients with HIV-1 infection with or without concomitant/active cocaine use? Does acute cocaine use enhance levels of these factors? Are these correlated with disease severity or heart disease occurrence? ,4) Do supernatants of mast cells and endothelial cells (activated by cocaine, norepinephrine, HIV-gp12O or tat) or sera of patients (with HIV- 1 infection, with or without concomitant/active cocaine use) contain factor/s that modulate macrophage function? Can antioxidants or NF-kappaB inhibitors modulate this process? This study will shed light on the pathogenesis of cardiovascular disease in a HIV-infected and/or cocaine-using population with multiple risk factors for immune-mediated vascular inflammation.
| Singh, Mahipal; Ananthula, Srinivas; Milhorn, Denise M et al. (2007) Osteopontin: a novel inflammatory mediator of cardiovascular disease. Front Biosci 12:214-21 |
| Kasasbeh, Aiman; Kasasbeh, Ehab; Krishnaswamy, Guha (2007) Potential mechanisms connecting asthma, esophageal reflux, and obesity/sleep apnea complex--a hypothetical review. Sleep Med Rev 11:47-58 |
| Krishnaswamy, Guha; Ajitawi, Omar; Chi, David S (2006) The human mast cell: an overview. Methods Mol Biol 315:13-34 |
| Chi, David S; Walker, Elaine S; Hossler, Fred E et al. (2006) Bacterial activation of mast cells. Methods Mol Biol 315:383-92 |
| Chi, David S; Fitzgerald, S Matthew; Krishnaswamy, Guha (2006) Mast cell histamine and cytokine assays. Methods Mol Biol 315:203-15 |
| Liu, Kai; Chi, David S; Li, Chuanfu et al. (2005) HIV-1 Tat protein-induced VCAM-1 expression in human pulmonary artery endothelial cells and its signaling. Am J Physiol Lung Cell Mol Physiol 289:L252-60 |
| Copeland, Billy; Aljitawi, Omar; Fitzgerald, Steven M et al. (2005) A patient with facial and neck swelling, dyspnea, and dysphagia. Ann Allergy Asthma Immunol 95:510-7 |
| Moorman, Jonathan P; Fitzgerald, S Matthew; Prayther, Deborah C et al. (2005) Induction of p38- and gC1qR-dependent IL-8 expression in pulmonary fibroblasts by soluble hepatitis C core protein. Respir Res 6:105 |
| Fitzgerald, S Matthew; Lee, Steven A; Hall, H Kenton et al. (2004) Human lung fibroblasts express interleukin-6 in response to signaling after mast cell contact. Am J Respir Cell Mol Biol 30:585-93 |
| Chi, David S; Fitzgerald, S Matthew; Pitts, Shannon et al. (2004) MAPK-dependent regulation of IL-1- and beta-adrenoreceptor-induced inflammatory cytokine production from mast cells: implications for the stress response. BMC Immunol 5:22 |
Showing the most recent 10 out of 24 publications
